FDA OK's Merck's new Gardasil; provides broader protection
This article was originally published in Scrip
Executive Summary
The FDA on 10 December OK'd a new version of Merck's human papillomavirus vaccine Gardasil, which is intended to provide broader protection against diseases caused by the virus.